Mersana Therapeutics ROE Ratio 2011-2026 | MRSN

Annual ROE Ratio Mersana Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
727.65	-465.18	-221.83	-139.69	-38.6	-36.02	-730.61	-55.3	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
727.65	-730.61	-119.95

Quarterly ROE Ratio Mersana Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-959.84	-2068.89	-2402.59	-1453.34	-1533.15	-516.58	-289.08	-227.64	-293.93	-280.4	-258.89	-138.88	-168.11	-131.05	-113.02	-67.69	-80.33	-60.96	-52.68	-47.8	-55.9	-66.78	-74.88	-82.97	-317.27	-551.57	-785.87	-1020.17	-785.08	-585.34	-385.6	-185.86	-168.16	-88.23	-8.3	47.0	49.26	24.63	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
49.26	-2402.59	-425.95

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
Amneal Pharmaceuticals AMRX	-101.78	$ 12.32	-	$ 3.86 B	USA
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	-8.52	$ 23.27	-	$ 2.96 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
BioNTech SE BNTX	1.11	$ 89.62	-	$ 27.2 B	Germany
Autolus Therapeutics plc AUTL	-161.42	$ 1.36	-	$ 362 M	Britain
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Burford Capital Limited BUR	10.1	$ 4.54	-	$ 764 M	Britain
Cabaletta Bio CABA	-149.8	$ 3.07	-	$ 308 M	USA
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	-36.22	$ 3.76	-	$ 9.05 B	Australia
CymaBay Therapeutics CBAY	-36.05	-	-	$ 3.45 B	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	-144.96	$ 3.03	-	$ 6.59 B	Israel
Aytu BioScience AYTU	-71.51	$ 2.57	-3.38 %	$ 16.1 M	USA
Avid Bioservices CDMO	-231.16	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	-103.99	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Checkpoint Therapeutics CKPT	445.47	-	-	$ 169 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	-88.4	-	-	$ 231 M	USA
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	-71.33	-	-	$ 401 M	USA
Cellectar Biosciences CLRB	-255.25	$ 2.75	-	$ 7.17 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	529.06	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	-43.82	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	-55.55	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	4.58	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	-53.24	$ 9.71	-	$ 129 M	USA
Curis CRIS	-138.81	$ 0.55	0.09 %	$ 7.24 M	USA
Coherus BioSciences CHRS	275.39	$ 1.67	-	$ 196 M	USA